Oncolytic viruses in head and neck cancer: a new ray of hope in the management protocol.

about

Polymeric oncolytic adenovirus for cancer gene therapy.Oncolytic reovirus therapy: Pilot study in dogs with spontaneously occurring tumours.Novel p53 therapies for head and neck cancer.

P2860

Q36344901-DCEE0016-FD2E-4FD6-8FA0-6946E0F1190B Q47596708-A560425B-7808-424B-A2A8-F9F5EAFB6149 Q52859512-BD491CE6-B0B2-4B09-8D54-DF29F32C774B

P2860

Oncolytic viruses in head and neck cancer: a new ray of hope in the management protocol.

Item

http://www.wikidata.org/entity/Q38264443

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Oncolytic viruses in head and neck cancer: a new ray of hope in the management protocol.

@en

type

Item

label

Oncolytic viruses in head and neck cancer: a new ray of hope in the management protocol.

@en

prefLabel

Oncolytic viruses in head and neck cancer: a new ray of hope in the management protocol.

@en

P1476

Oncolytic viruses in head and neck cancer: a new ray of hope in the management protocol.

@en

P2093

N Sultana

http://www.w3.org/2001/XMLSchema#string

P Pandeshwar

http://www.w3.org/2001/XMLSchema#string

Ps Shilpa

http://www.w3.org/2001/XMLSchema#string

R Kaul

http://www.w3.org/2001/XMLSchema#string

S Bhat

http://www.w3.org/2001/XMLSchema#string

P2860

Viruses and Apoptosis

Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family

p53-dependent apoptosis modulates the cytotoxicity of anticancer agents

Cancer gene-therapy: clinical trials.

Capsid assembly and DNA packaging in herpes simplex virus.

Oncolytic Viruses for Cancer Therapy: Overcoming the Obstacles.

Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus.

a controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer.

Selective replication and oncolysis in p53 mutant tumors with ONYX-015, an E1B-55kD gene-deleted adenovirus, in patients with advanced head and neck cancer: a phase II trial.

Viral oncolysis.

P304

S178-84

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4103/2141-9248.141953

http://www.w3.org/2001/XMLSchema#string

P433

Suppl 3

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

267754067

http://www.w3.org/2001/XMLSchema#string

P698

25364586

http://www.w3.org/2001/XMLSchema#string

P921

oncolytic virus

P932

4212374

http://www.w3.org/2001/XMLSchema#string

Oncolytic viruses in head and neck cancer: a new ray of hope in the management protocol.

about

P2860

P2860

Oncolytic viruses in head and neck cancer: a new ray of hope in the management protocol.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932